Regeneron Pharmaceuticals Inc (REGN) stock chart and technical analysis

Indicator summary: Leaning bullish (3 bullish, 1 bearish, 1 neutral). As of 2026-09-18, the close was $784.85: 2.8% above the 50-day average and 7.2% above the 200-day average, which is rising. RSI (14) is 48, in its neutral range. MACD is bearish. The stock sits 77% of the way up its 52-week range of $538.30 to $859.34, on 4.1x its 20-day average volume.

Indicator	Reading	Read
50-day average	$763.12	Price 2.8% above
200-day average	$732.18	Price 7.2% above, average rising
50 vs 200-day	50 above 200	Golden-cross alignment
RSI (14)	48	Neutral range
MACD (12, 26, 9)	+2.42 vs +10.49	Line below signal
52-week range	$538.30 to $859.34	77% of the way up the range
Volume vs 20-day average	4.1x	Heavy

What followed this setup for REGN

When it closed above its 200-day average (3,978 days), it was higher 63 trading days later 55% of the time, median +2.4%.
When it closed above its 50-day average (3,707 days), it was higher 63 trading days later 53% of the time, median +1.5%.
When it had MACD below its signal line (3,356 days), it was higher 63 trading days later 57% of the time, median +3.8%.
All days since 1999 (6,698 days): higher 63 trading days later 57% of the time, median +3.6%.

Base rates use REGN's own daily history since 1999; they describe the past, not a forecast.

ŷRobot chart signal: Sell, from the chart signal model.

REGN analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks

ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.